Literature DB >> 20069079

Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease.

Mohammad Madjid1, Anushayanthan Alfred, Achal Sahai, Jodie L Conyers, S Ward Casscells.   

Abstract

Vaccination against influenza averts cardiovascular events and is recommended for all patients with coronary heart disease. Because data were unavailable regarding vaccination rates among such patients' household contacts, we sought to estimate the rate of influenza vaccination in persons with cardiovascular disease and their contacts. In 2004, we conducted a random, nationwide telephone survey of 1,202 adults (age, > or = 18 yr) to ascertain knowledge, attitudes, and behaviors regarding influenza vaccination. Of the interviewees, 134 (11.1%) had histories of heart disease or stroke. Of these 134, 57% were men, and 45% were > or = 65 years of age. Overall, 57% were inoculated against influenza in 2003-2004, and 68% intended the same during 2004-2005. Vaccination rates increased with age: 48% (ages, 18-49 yr), 68% (ages, 50-64 yr), and 75% (age, > or = 65 yr). Forty of 69 respondents (58%) reported that their spouses were vaccinated, and 7 of 21 (33%) reported the inoculation of children < or = 17 years old in their household. Only 65% of the 134 patients considered themselves to be of high-risk status. Chief reasons for remaining unvaccinated were disbelief in being at risk and fear of contracting influenza from the vaccine. Although seasonal influenza vaccination is recommended for all coronary heart disease patients and their household contacts, the practice is less prevalent than is optimal. Intensified approaches are needed to increase vaccination rates. These findings suggest a need to increase vaccination efforts in high-risk subjects, particularly amidst the emerging H1N1 pandemic.

Entities:  

Keywords:  Advisory committees/statistics & numerical data/trends; United States/epidemiology; age factors; cardiovascular diseases/etiology/prevention & control/virology; cost of illness; health care surveys; health policy; infectious disease transmission; influenza vaccines/administration & dosage/economics/supply & distribution/therapeutic use; influenza, human/complications/epidemiology/immunology/mortality/prevention & control/transmission; risk factors; vaccination/economics/standards/statistics & numerical data/utilization

Mesh:

Substances:

Year:  2009        PMID: 20069079      PMCID: PMC2801927     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  36 in total

1.  Update: influenza vaccine supply and recommendations for prioritization during the 2005-06 influenza season.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-09-02       Impact factor: 17.586

2.  Influenza vaccination levels among persons aged > or =65 years and among persons aged 18-64 years with high-risk conditions--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-10-21       Impact factor: 17.586

3.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

Authors:  Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

4.  Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.

Authors:  Matthew M Davis; Kathryn Taubert; Andrea L Benin; David W Brown; George A Mensah; Larry M Baddour; Sandra Dunbar; Harlan M Krumholz
Journal:  Circulation       Date:  2006-09-18       Impact factor: 29.690

5.  Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.

Authors:  C B Bridges; W W Thompson; M I Meltzer; G R Reeve; W J Talamonti; N J Cox; H A Lilac; H Hall; A Klimov; K Fukuda
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

6.  Influenza vaccination is associated with a reduced risk of stroke.

Authors:  Armin J Grau; Beate Fischer; Cordula Barth; Paul Ling; Christoph Lichy; Florian Buggle
Journal:  Stroke       Date:  2005-06-09       Impact factor: 7.914

7.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

8.  Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study.

Authors:  Andrzej Ciszewski; Zofia T Bilinska; Lidia B Brydak; Cezary Kepka; Mariusz Kruk; Magdalena Romanowska; Ewa Ksiezycka; Jakub Przyluski; Walerian Piotrowski; Renata Maczynska; Witold Ruzyllo
Journal:  Eur Heart J       Date:  2008-01-10       Impact factor: 29.983

9.  Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.

Authors:  Pedro A Piedra; Manjusha J Gaglani; Claudia A Kozinetz; Gayla Herschler; Mark Riggs; Melissa Griffith; Charles Fewlass; Matt Watts; Colin Hessel; Julie Cordova; W Paul Glezen
Journal:  Vaccine       Date:  2005-02-18       Impact factor: 3.641

10.  Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects.

Authors:  Mohammad Madjid; Charles C Miller; Vladimir V Zarubaev; Ivan G Marinich; Oleg I Kiselev; Yury V Lobzin; Alexander E Filippov; Samuel Ward Casscells
Journal:  Eur Heart J       Date:  2007-04-17       Impact factor: 29.983

View more
  13 in total

1.  A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June 14, 2011.

Authors: 
Journal:  Public Health Rep       Date:  2012 Jan-Feb       Impact factor: 2.792

2.  A Blueprint for Improving the Promotion and Delivery of Adult Vaccination in the United States.

Authors:  Katherine M Harris; Lori Uscher-Pines; Soeren Mattke; Arthur L Kellermann
Journal:  Rand Health Q       Date:  2012-03-01

3.  The public acceptance of smallpox vaccination to fight bioterrorism in Japan: results of a large-scale opinion survey in Japan.

Authors:  Hajime Sato; Jun Tomio; Yoshiaki Tanaka; Emiko Iwasaki
Journal:  Environ Health Prev Med       Date:  2010-12-21       Impact factor: 3.674

Review 4.  Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.

Authors:  Isabel Leroux-Roels; Françoise Weber
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

5.  Perceptions of and willingness to engage in public health precautions to prevent 2009 H1N1 influenza transmission.

Authors:  Marc T Kiviniemi; Pavani K Ram; Lynn T Kozlowski; Kaitlin M Smith
Journal:  BMC Public Health       Date:  2011-03-08       Impact factor: 3.295

6.  Determinants of refusal of A/H1N1 pandemic vaccination in a high risk population: a qualitative approach.

Authors:  Eugenie d'Alessandro; Dominique Hubert; Odile Launay; Laurence Bassinet; Olivier Lortholary; Yannick Jaffre; Isabelle Sermet-Gaudelus
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

7.  Acute myocardial infarction and influenza: a meta-analysis of case-control studies.

Authors:  Michelle Barnes; Anita E Heywood; Abela Mahimbo; Bayzid Rahman; Anthony T Newall; C Raina Macintyre
Journal:  Heart       Date:  2015-08-26       Impact factor: 5.994

8.  The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers.

Authors:  D M MacDougall; B A Halperin; D MacKinnon-Cameron; Li Li; S A McNeil; J M Langley; S A Halperin
Journal:  BMJ Open       Date:  2015-09-29       Impact factor: 2.692

9.  Safety and tolerability of intradermal influenza vaccination in patients with cardiovascular disease.

Authors:  Arintaya Phrommintikul; Wanwarang Wongcharoen; Srun Kuanprasert; Narawudt Prasertwitayakij; Rungsrit Kanjanavanit; Siriluck Gunaparn; Apichard Sukonthasarn
Journal:  J Geriatr Cardiol       Date:  2014-06       Impact factor: 3.327

Review 10.  Influenza vaccine as a coronary intervention for prevention of myocardial infarction.

Authors:  C Raina MacIntyre; Abela Mahimbo; Aye M Moa; Michelle Barnes
Journal:  Heart       Date:  2016-09-29       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.